Gyre Therapeutics Inc (GYRE): Next-Year EPS Estimate 65.52%
As of 2026-06-11, Gyre Therapeutics Inc (GYRE) has a next-year EPS growth estimate of 65.52%.
On 2026-05-11, analyst consensus for GYRE's next-year EPS growth shifted from 64.29% to 65.52% — a positive change of 1.23 percentage points. The revised estimate has been sustained across 24 subsequent trading sessions. Current-year growth is projected at -1550.00%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 65.52%
- EPS growth this year
- -1550.00%
- EPS next quarter (est)
- -$0.06
- Last price
- $6.06
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 65.52% | -1550.00% | -$0.06 | $6.06 |
| 2026-06-10 | 65.52% | -1550.00% | -$0.06 | $5.95 |
| 2026-06-09 | 65.52% | -1550.00% | -$0.06 | $6.13 |
| 2026-06-08 | 65.52% | -1550.00% | -$0.06 | $6.05 |
| 2026-06-07 | 65.52% | -1550.00% | -$0.06 | $6.29 |
| 2026-06-04 | 65.52% | -1550.00% | -$0.06 | $6.19 |
| 2026-06-03 | 65.52% | -1550.00% | -$0.06 | $5.69 |
| 2026-06-02 | 65.52% | -1550.00% | -$0.06 | $5.56 |
| 2026-06-01 | 65.52% | -1550.00% | -$0.06 | $5.81 |
| 2026-05-31 | 65.52% | -1550.00% | -$0.06 | $5.91 |
| 2026-05-28 | 65.52% | -1550.00% | -$0.06 | $5.74 |
| 2026-05-27 | 65.52% | -1550.00% | -$0.06 | $5.92 |
| 2026-05-26 | 65.52% | -1550.00% | -$0.06 | $5.94 |
| 2026-05-25 | 65.52% | -1550.00% | -$0.06 | $6.06 |
| 2026-05-24 | 65.52% | -1550.00% | -$0.06 | $6.06 |
| 2026-05-21 | 65.52% | -1550.00% | -$0.06 | $6.18 |
| 2026-05-20 | 65.52% | -1550.00% | -$0.06 | $6.04 |
| 2026-05-19 | 65.52% | -1550.00% | -$0.06 | $6.26 |
| 2026-05-18 | 65.52% | -1550.00% | -$0.06 | $6.44 |
| 2026-05-17 | 65.52% | -1550.00% | -$0.06 | $6.55 |
| 2026-05-14 | 65.52% | -1550.00% | -$0.06 | $7.00 |
| 2026-05-13 | 65.52% | -1550.00% | -$0.06 | $7.27 |
| 2026-05-12 | 65.52% | -1550.00% | -$0.06 | $7.30 |
| 2026-05-11 | 65.52% | -1550.00% | -$0.06 | $7.09 |
| 2026-05-10 | 64.29% | -1500.00% | -$0.06 | $7.47 |
| 2026-05-07 | 30.36% | -1500.00% | -$0.06 | $7.07 |
| 2026-05-06 | 39.06% | -1700.00% | -$0.07 | $8.04 |
| 2026-05-05 | 39.06% | -1700.00% | -$0.07 | $7.78 |
| 2026-05-04 | 39.06% | -1700.00% | -$0.07 | $7.92 |
| 2026-05-03 | 39.06% | -1700.00% | -$0.07 | $7.80 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Gyre Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Gyre Therapeutics Inc (GYRE) has a next-year EPS growth estimate of 65.52%, based on analyst consensus.
When was the latest EPS estimate revision for GYRE?▾
The most recent revision occurred on 2026-05-11, when analysts adjusted the next-year EPS growth estimate from 64.29% to 65.52%.
What sector and industry does Gyre Therapeutics Inc belong to?▾
Gyre Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. GYRE appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Gyre Therapeutics Inc (GYRE) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports